Inotiv, Inc.Inotiv, Inc.Inotiv, Inc.

Inotiv, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪132.57 M‬EUR
−3.7620EUR
‪−97.40 M‬EUR
‪440.75 M‬EUR
‪27.98 M‬
Beta (1Y)
4.79
Employees (FY)
‪2.08 K‬
Change (1Y)
+120 +6.14%
Revenue / Employee (1Y)
‪212.41 K‬EUR
Net income / Employee (1Y)
‪−46.94 K‬EUR

About Inotiv, Inc.


CEO
Robert W. Leasure
Headquarters
West Lafayette
Founded
1974
FIGI
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Inotiv, Inc. stocks are traded under the ticker A2QRE5.
A2QRE5 stock has fallen by −2.86% compared to the previous week, the month change is a −2.86% fall, over the last year Inotiv, Inc. has showed a −2.86% decrease.
We've gathered analysts' opinions on Inotiv, Inc. future price: according to them, A2QRE5 price has a max estimate of 9.60 EUR and a min estimate of 3.84 EUR. Watch A2QRE5 chart and read a more detailed Inotiv, Inc. stock forecast: see what analysts think of Inotiv, Inc. and suggest that you do with its stocks.
A2QRE5 stock is 3.43% volatile and has beta coefficient of 4.79. Track Inotiv, Inc. stock price on the chart and check out the list of the most volatile stocks — is Inotiv, Inc. there?
Yes, you can track Inotiv, Inc. financials in yearly and quarterly reports right on TradingView.
Inotiv, Inc. is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
A2QRE5 earnings for the last quarter are −0.66 EUR per share, whereas the estimation was −0.88 EUR resulting in a 25.13% surprise. The estimated earnings for the next quarter are −0.71 EUR per share. See more details about Inotiv, Inc. earnings.
Inotiv, Inc. revenue for the last quarter amounts to ‪117.13 M‬ EUR, despite the estimated figure of ‪105.03 M‬ EUR. In the next quarter, revenue is expected to reach ‪118.55 M‬ EUR.
A2QRE5 net income for the last quarter is ‪−16.97 M‬ EUR, while the quarter before that showed ‪−24.35 M‬ EUR of net income which accounts for 30.34% change. Track more Inotiv, Inc. financial stats to get the full picture.
No, A2QRE5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 17, 2025, the company has ‪2.08 K‬ employees. See our rating of the largest employees — is Inotiv, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inotiv, Inc. EBITDA is ‪−11.33 M‬ EUR, and current EBITDA margin is 1.50%. See more stats in Inotiv, Inc. financial statements.
Like other stocks, A2QRE5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inotiv, Inc. stock right from TradingView charts — choose your broker and connect to your account.